() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: HMLSF

MedReleaf’s Analyst Ratings and Price Target

MedReleaf Corp (LEAF) has a market capitalization of about 1.8 billion Canadian dollars. Unlike Canopy Growth (WEED), Aphria (APHQF), and Aurora Cannabis (ACBFF), which have been around for a while, MedReleaf came out with its IPO in June 2017 at a price of 9.50 Canadian dollars.
Read more

Canopy Growth’s Analyst Ratings and Price Target

Canopy Growth's Analyst Ratings and Price Target Canopy Growth Canopy Growth (WEED) has a market capitalization of 5.7 billion Canadian dollars. The stock rose ~132.0% to 28.80 Canadian dollars on February 6. Over a one-year period, the positive regulatory sentiment toward the cannabis industry (HMLSF) also garnered price upgrades from analysts. Let’s look at where…
Read more